Page 6

Basic Information About DATA On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of schedule III, IV or V opioid treatment drugs that are approved by the FDA for maintenance or detoxification treatment. Summary of Title XXXV NIDA/SAMHSA Announcement & Press Release NIDA Research and…

Page One  Page Two  Page Three  Page Four  Page Five  Page Six  Page Seven  NAMA Advocate Index 

These documents communicate the aspects of what quality methadone maintenance treatment should be. This is not a complete list of the Policy Statements that NAMA has issued.  Some important research by addiction treatment experts has been added. Methadone Medical Maintenance Policy Statement 1 April 1994 The Policy of Blind Dosing and Patient Dignity Policy Statement…

Methadone Maintenance and Other Pharmacotherapeutic Interventions in the Treatment of Opioid Dependence. Overview Drug Courts are being confronted with increasing numbers of opiate dependent offenders. This Fact Sheet is intended to dispel misperceptions and educate practitioners about the efficacy of medication assisted treatment. Opioid dependence is a devastating reality and a treatable disease. According to…

Methadone Advocate Training   Want to know what a Methadone Conference is like? Check out our report on the NAMA website www.methadone.org                         FIRST EVER METHADONE (MAT) ADVOCATE TRAINING AND CERTIFICATION AT THE 2003 AATOD CONFERENCE IN Washington, DC SATURDAY APRIL 12, 2003 Information about the first ever CMA Training at AATOD on April 12,…

Monday, October 18, 2004 One-By-One Just before the meeting the chapters start strolling in. Walking toward the table Howard Lotsof (NAMA), and standing in the doorway is Sharon Dembinski (NE NAMA-MOM) and Barbara Finger (TexNAMA), Charles Kitts (VA NAMA), Cheri Jarvis (VA NAMA) and Paul Bowman (Boston NAMA) discuss chapter issues, sitting at the end…